- Conditions
- Deep Vein Thrombosis (DVT), Thrombus in the Peripheral Venous Vasculature, Venous Embolism, Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts
- Interventions
- Aspiration thrombectomy system
- Device
- Lead sponsor
- Argon Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 185 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 4
- States / cities
- Fort Lauderdale, Florida • Tampa, Florida • Edgewood, Kentucky + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 49
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Cerebral Stroke
- Interventions
- EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter, CEREGLIDE 71 Intermediate Catheter
- Device
- Lead sponsor
- Cerenovus, Part of DePuy Synthes Products, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2025
- U.S. locations
- 30
- States / cities
- Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 24 more
- Conditions
- Acute Stroke
- Interventions
- Acute Endovascular Stroke Treatment
- Other
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 191 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 4
- States / cities
- New York, New York
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, Cerebrovascular Disorders, Ischemia, Nervous System Diseases, Pathologic Processes, Stroke, Ischemic, Stroke, Acute, Vascular Diseases
- Interventions
- Mechanical Thrombectomy using the pRESET Thrombectomy device, Mechanical Thrombectomy using the Solitaire Revascularization Device
- Device
- Lead sponsor
- phenox Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 340 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 19
- States / cities
- Scottsdale, Arizona • Santa Monica, California • Coral Gables, Florida + 15 more
- Conditions
- Ischemic Stroke
- Interventions
- Mechanical Thrombectomy
- Procedure
- Lead sponsor
- Stryker Neurovascular
- Industry
- Eligibility
- Not listed
- Enrollment
- 1,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 1
- States / cities
- Kansas City, Missouri
- Conditions
- Stroke, Acute, Blood Pressure, Mechanical Thrombectomy
- Interventions
- Clevidipine
- Drug
- Lead sponsor
- ProMedica Health System
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 1
- States / cities
- Toledo, Ohio
- Conditions
- Critical Limb Ischemia
- Interventions
- Endovascular peripheral intervention
- Device
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Stroke
- Interventions
- Pre-pandemic stroke related metrics, Stroke related metrics during the pandemic
- Other
- Lead sponsor
- Boston Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 345,089 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 2
- States / cities
- Atlanta, Georgia • Boston, Massachusetts
- Conditions
- Stroke, Ischemia Stroke, Hemorrhagic Strokes, Mortality, Morbidity, Cerebrovascular Accident (Stroke), Intracerebral Haemorrhage (ICH)
- Interventions
- Minocycline 200mg
- Drug
- Lead sponsor
- Joyce Chen
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,164 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Brooklyn, New York
- Conditions
- Acute Ischemic Stroke
- Interventions
- J147 Emulsion for Injection, Placebo
- Drug · Other
- Lead sponsor
- Abrexa Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 196 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Cerebrovascular Disorders, Acute Cerebrovascular Disease
- Interventions
- iNO
- Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 2
- States / cities
- Charlotte, North Carolina
- Conditions
- Hyperplasia, Stenosis
- Interventions
- angioplasty, stent placement
- Procedure
- Lead sponsor
- National Kidney Foundation, United States
- Other
- Eligibility
- 19 Years and older
- Enrollment
- 130 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2010
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Stroke, Ischemia
- Interventions
- EmboTrap® Revascularization Device
- Device
- Lead sponsor
- Neuravi Inc.
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 228 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 9
- States / cities
- Los Angeles, California • San Jose, California • Miami, Florida + 6 more
- Conditions
- Ischemic Stroke
- Interventions
- Tigertriever revascularization device
- Device
- Lead sponsor
- Rapid Medical
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 16
- States / cities
- Los Angeles, California • Thousand Oaks, California • Coral Springs, Florida + 12 more
- Conditions
- Intracranial Stenosis, Large Vessel Occlusion, Mechanical Thrombectomy
- Interventions
- No Intervention
- Other
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 14
- States / cities
- New Haven, Connecticut • Miami, Florida • Atlanta, Georgia + 11 more
- Conditions
- Stroke, Large Vessel Occlusion
- Interventions
- Mechanical thrombectomy via blood flow reversal using BOBBY balloon guide catheter
- Device
- Lead sponsor
- MediSys Health Network
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025
- U.S. locations
- 1
- States / cities
- Jamaica, New York
- Conditions
- Ischemic Stroke
- Interventions
- Not listed
- Lead sponsor
- Stryker Neurovascular
- Industry
- Eligibility
- Not listed
- Enrollment
- 2,008 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 47
- States / cities
- Mesa, Arizona • Phoenix, Arizona • Castro Valley, California + 40 more
- Conditions
- Ischemic Stroke
- Interventions
- SOLITAIRE™ Device, MERCI® Device
- Device
- Lead sponsor
- Medtronic Neurovascular Clinical Affairs
- Industry
- Eligibility
- 22 Years to 85 Years
- Enrollment
- 144 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 2
- States / cities
- Portland, Oregon • Tacoma, Washington
- Conditions
- Ischemic Stroke
- Interventions
- Mechanical Thrombectomy
- Device
- Lead sponsor
- Stryker Neurovascular
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 178 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Portland, Oregon
- Conditions
- Acute Ischemic Stroke, Vessel Occlusion, Stroke, Ischemic
- Interventions
- MicroVention Mechanical Thrombectomy Devices as first-line treatment
- Device
- Lead sponsor
- Microvention-Terumo, Inc.
- Industry
- Eligibility
- Not listed
- Enrollment
- 710 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 37
- States / cities
- Burbank, California • Carmichael, California • Redwood City, California + 34 more
- Conditions
- Acute Ischemic Stroke Patients
- Interventions
- Anesthesia drugs during the surgery
- Procedure
- Lead sponsor
- University of Kansas Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Kansas City, Kansas
- Conditions
- Ischemic Stroke
- Interventions
- 3K3A-APC, Placebo
- Biological · Drug
- Lead sponsor
- ZZ Biotech, LLC
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 110 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 15
- States / cities
- Los Angeles, California • Chicago, Illinois • Kansas City, Kansas + 12 more
- Conditions
- Acute Deep Venous Thrombosis of Ileofemoral Vein
- Interventions
- Thrombectomy
- Device
- Lead sponsor
- Paul J. Gagne
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 6
- States / cities
- Darien, Connecticut • Hyannis, Massachusetts • Leominster, Massachusetts + 3 more
- Conditions
- Deep Vein Thrombosis, Venous Thrombosis, Postphlebitic Syndrome, Venous Thromboembolism, Post Thrombotic Syndrome
- Interventions
- Recombinant tissue plasminogen activator (rt-PA)
- Drug
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- 16 Years to 75 Years
- Enrollment
- 692 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2017
- U.S. locations
- 56
- States / cities
- Glendale, Arizona • Orange, California • Stanford, California + 48 more